Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
J Biol Chem ; 289(30): 20477-88, 2014 Jul 25.
Article in English | MEDLINE | ID: mdl-24904063

ABSTRACT

HIV-1 replication in the presence of antiviral agents results in evolution of drug-resistant variants, motivating the search for additional drug classes. Here we report studies of GSK1264, which was identified as a compound that disrupts the interaction between HIV-1 integrase (IN) and the cellular factor lens epithelium-derived growth factor (LEDGF)/p75. GSK1264 displayed potent antiviral activity and was found to bind at the site occupied by LEDGF/p75 on IN by x-ray crystallography. Assays of HIV replication in the presence of GSK1264 showed only modest inhibition of the early infection steps and little effect on integration targeting, which is guided by the LEDGF/p75-IN interaction. In contrast, inhibition of late replication steps was more potent. Particle production was normal, but particles showed reduced infectivity. GSK1264 promoted aggregation of IN and preformed LEDGF/p75-IN complexes, suggesting a mechanism of inhibition. LEDGF/p75 was not displaced from IN during aggregation, indicating trapping of LEDGF/p75 in aggregates. Aggregation assays with truncated IN variants revealed that a construct with catalytic and C-terminal domains of IN only formed an open polymer associated with efficient drug-induced aggregation. These data suggest that the allosteric inhibitors of IN are promising antiviral agents and provide new information on their mechanism of action.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , HIV Integrase/metabolism , HIV-1/physiology , Protein Multimerization , Transcription Factors/metabolism , Virus Replication/drug effects , Adaptor Proteins, Signal Transducing/chemistry , Adaptor Proteins, Signal Transducing/genetics , Allosteric Regulation/drug effects , Allosteric Regulation/genetics , Cell Line , Crystallography, X-Ray , HIV Integrase/chemistry , HIV Integrase/genetics , HIV Integrase Inhibitors/pharmacology , Humans , Protein Structure, Tertiary , Transcription Factors/chemistry , Transcription Factors/genetics , Virus Replication/physiology
2.
Proc Natl Acad Sci U S A ; 110(25): E2279-87, 2013 Jun 18.
Article in English | MEDLINE | ID: mdl-23723351

ABSTRACT

The transposon piggyBac is being used increasingly for genetic studies. Here, we describe modified versions of piggyBac transposase that have potentially wide-ranging applications, such as reversible transgenesis and modified targeting of insertions. piggyBac is distinguished by its ability to excise precisely, restoring the donor site to its pretransposon state. This characteristic makes piggyBac useful for reversible transgenesis, a potentially valuable feature when generating induced pluripotent stem cells without permanent alterations to genomic sequence. To avoid further genome modification following piggyBac excision by reintegration, we generated an excision competent/integration defective (Exc(+)Int(-)) transposase. Our findings also suggest the position of a target DNA-transposase interaction. Another goal of genome engineering is to develop reagents that can guide transgenes to preferred genomic regions. Others have shown that piggyBac transposase can be active when fused to a heterologous DNA-binding domain. An Exc(+)Int(-) transposase, the intrinsic targeting of which is defective, might also be a useful intermediate in generating a transposase whose integration activity could be rescued and redirected by fusion to a site-specific DNA-binding domain. We show that fusion to two designed zinc finger proteins rescued the Int(-) phenotype. Successful guided transgene integration into genomic DNA would have broad applications to gene therapy and molecular genetics. Thus, an Exc(+)Int(-) transposase is a potentially useful reagent for genome engineering and provides insight into the mechanism of transposase-target DNA interaction.


Subject(s)
DNA Transposable Elements/genetics , Genetic Engineering/methods , Nerve Tissue Proteins/genetics , Saccharomyces cerevisiae/genetics , Amino Acid Sequence , Animals , Gene Transfer Techniques , Genome, Human/genetics , HEK293 Cells , HeLa Cells , Humans , Mammals , Molecular Sequence Data , Mutagenesis, Insertional/methods , Pluripotent Stem Cells/cytology , Pluripotent Stem Cells/physiology , Zinc Fingers/genetics
3.
Hum Gene Ther ; 24(5): 520-5, 2013 May.
Article in English | MEDLINE | ID: mdl-23621841

ABSTRACT

Recombinant adeno-associated viruses (rAAVs) have been tested in humans and other large mammals without adverse events. However, one study of mucopolysaccharidosis VII correction in mice showed repeated integration of rAAV in cells from hepatocellular carcinoma (HCC) in the Dlk1-Dio3 locus, suggesting possible insertional mutagenesis. In contrast, another study found no association of rAAV integration with HCC, raising questions about the generality of associations between liver transformation and integration at Dlk1-Dio3. Here we report that in rAAV-treated ornithine transcarbamylase (Otc)-deficient mice, four examples of integration sites in Dlk1-Dio3 could be detected in specimens from liver nodule/tumors, confirming previous studies of rAAV integration in the Dlk1-Dio3 locus in the setting of another murine model of metabolic disease. In one case, the integrated vector was verified to be present at about one copy per cell, consistent with clonal expansion. Another verified integration site in liver nodule/tumor tissue near the Tax1bp1 gene was also detected at about one copy per cell. The Dlk1-Dio3 region has also been implicated in human HCC and so warrants careful monitoring in ongoing human clinical trials with rAAV vectors.


Subject(s)
Carcinoma, Hepatocellular/genetics , Dependovirus/genetics , Genetic Vectors/adverse effects , Mucopolysaccharidosis VII/therapy , Ornithine Carbamoyltransferase/therapeutic use , Calcium-Binding Proteins , Carcinoma, Hepatocellular/etiology , Carcinoma, Hepatocellular/virology , Clinical Trials as Topic , Genetic Therapy/adverse effects , Intercellular Signaling Peptides and Proteins/genetics , Iodide Peroxidase/genetics , Liver/pathology , Mucopolysaccharidosis VII/complications , Mucopolysaccharidosis VII/genetics , Ornithine Carbamoyltransferase/drug effects , Ornithine Carbamoyltransferase/genetics , Virus Integration/genetics
4.
J Virol Methods ; 189(1): 53-7, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23348058

ABSTRACT

In many studies of HIV replication, it is useful to quantify the number of HIV proviruses in cells against a background of unintegrated forms of the HIV DNA. A popular method for doing so involves quantitative PCR using one primer complementary to the HIV long terminal repeat (LTR), and a second primer complementary to a cellular Alu repeat, so that PCR product only forms from templates where a provirus is integrated in the human genome near an Alu repeat. However, several recent studies have identified conditions that alter distributions of HIV integration sites relative to genes. Because Alu repeats are enriched in gene rich regions, this raises the question of whether altered integration site distributions might confound provirus abundance measurements using the Alu-PCR method. Here modified versions of the HIV tethering protein LEDGF/p75 were used to retarget HIV integration outside of transcription units, and show that this has a negligible effect on Alu-PCR quantitation of proviral abundance. Thus altered integration targeting, at least to the degree achieved here, is not a major concern when using the Alu-PCR assay.


Subject(s)
Alu Elements/genetics , DNA, Viral/genetics , HIV Infections/virology , HIV-1/genetics , Intercellular Signaling Peptides and Proteins/genetics , Cell Line , HeLa Cells , Humans , Proviruses/genetics , RNA Interference , RNA, Small Interfering , Virus Integration
5.
Blood ; 121(9): 1524-33, 2013 Feb 28.
Article in English | MEDLINE | ID: mdl-23264589

ABSTRACT

We report the safety and tolerability of 87 infusions of lentiviral vector­modified autologous CD4 T cells (VRX496-T; trade name, Lexgenleucel-T) in 17 HIV patients with well-controlled viremia. Antiviral effects were studied during analytic treatment interruption in a subset of 13 patients. VRX496-T was associated with a decrease in viral load set points in 6 of 8 subjects (P = .08). In addition, A → G transitions were enriched in HIV sequences after infusion, which is consistent with a model in which transduced CD4 T cells exert antisense-mediated genetic pressure on HIV during infection. Engraftment of vector-modified CD4 T cells was measured in gut-associated lymphoid tissue and was correlated with engraftment in blood. The engraftment half-life in the blood was approximately 5 weeks, with stable persistence in some patients for up to 5 years. Conditional replication of VRX496 was detected periodically through 1 year after infusion. No evidence of clonal selection of lentiviral vector­transduced T cells or integration enrichment near oncogenes was detected. This is the first demonstration that gene-modified cells can exert genetic pressure on HIV. We conclude that gene-modified T cells have the potential to decrease the fitness of HIV-1 and conditionally replicative lentiviral vectors have a promising safety profile in T cells.


Subject(s)
CD4-Positive T-Lymphocytes/transplantation , Genetic Therapy/methods , HIV Infections/therapy , HIV-1/genetics , Lentivirus/genetics , Oligonucleotides, Antisense/pharmacology , Adoptive Transfer/methods , Adult , Antiviral Agents/adverse effects , Antiviral Agents/metabolism , Antiviral Agents/pharmacology , CD4-Positive T-Lymphocytes/metabolism , CD4-Positive T-Lymphocytes/physiology , Female , Genetic Therapy/adverse effects , Genetic Vectors/adverse effects , Genetic Vectors/metabolism , Genetic Vectors/pharmacology , HIV Infections/genetics , HIV Infections/immunology , HIV-1/immunology , Humans , Lentivirus/metabolism , Lentivirus/physiology , Male , Middle Aged , Oligonucleotides/administration & dosage , Oligonucleotides/genetics , Oligonucleotides, Antisense/administration & dosage , Oligonucleotides, Antisense/adverse effects , Oligonucleotides, Antisense/genetics , Transduction, Genetic/methods , Viral Load/drug effects , Virus Replication/genetics
6.
PLoS Pathog ; 8(7): e1002818, 2012.
Article in English | MEDLINE | ID: mdl-22911005

ABSTRACT

Despite the effectiveness of highly active antiretroviral therapy (HAART) in treating individuals infected with HIV, HAART is not a cure. A latent reservoir, composed mainly of resting CD4+T cells, drives viral rebound once therapy is stopped. Understanding the formation and maintenance of latently infected cells could provide clues to eradicating this reservoir. However, there have been discrepancies regarding the susceptibility of resting cells to HIV infection in vitro and in vivo. As we have previously shown that resting CD4+T cells are susceptible to HIV integration, we asked whether these cells were capable of producing viral proteins and if so, why resting cells were incapable of supporting productive infection. To answer this question, we spinoculated resting CD4+T cells with or without prior stimulation, and measured integration, transcription, and translation of viral proteins. We found that resting cells were capable of producing HIV Gag without supporting spreading infection. This block corresponded with low HIV envelope levels both at the level of protein and RNA and was not an artifact of spinoculation. The defect was reversed upon stimulation with IL-7 or CD3/28 beads. Thus, a population of latent cells can produce viral proteins without resulting in spreading infection. These results have implications for therapies targeting the latent reservoir and suggest that some latent cells could be cleared by a robust immune response.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD4-Positive T-Lymphocytes/virology , HIV-1/physiology , Virus Latency , env Gene Products, Human Immunodeficiency Virus/biosynthesis , gag Gene Products, Human Immunodeficiency Virus/biosynthesis , CD28 Antigens/metabolism , CD3 Complex/metabolism , Cells, Cultured , Gene Expression Regulation, Viral , HIV Infections/immunology , HIV-1/immunology , HIV-1/metabolism , Humans , Interleukin-17/metabolism , Interleukin-7/immunology , Macrophage Inflammatory Proteins/immunology , Virus Replication
7.
Sci Transl Med ; 4(132): 132ra53, 2012 May 02.
Article in English | MEDLINE | ID: mdl-22553251

ABSTRACT

The success of adoptive T cell gene transfer for treatment of cancer and HIV is predicated on generating a response that is both durable and safe. We report long-term results from three clinical trials to evaluate gammaretroviral vector-engineered T cells for HIV. The vector encoded a chimeric antigen receptor (CAR) composed of CD4 linked to the CD3ζ signaling chain (CD4ζ). CAR T cells were detected in 98% of samples tested for at least 11 years after infusion at frequencies that exceeded average T cell levels after most vaccine approaches. The CD4ζ transgene retained expression and function. There was no evidence of vector-induced immortalization of cells; integration site distributions showed no evidence of persistent clonal expansion or enrichment for integration sites near genes implicated in growth control or transformation. The CD4ζ T cells had stable levels of engraftment, with decay half-lives that exceeded 16 years, in marked contrast to previous trials testing engineered T cells. These findings indicate that host immunosuppression before T cell transfer is not required to achieve long-term persistence of gene-modified T cells. Further, our results emphasize the safety of T cells modified by retroviral gene transfer in clinical application, as measured in >500 patient-years of follow-up. Thus, previous safety issues with integrating viral vectors are hematopoietic stem cell or transgene intrinsic, and not a general feature of retroviral vectors. Engineered T cells are a promising form of synthetic biology for long-term delivery of protein-based therapeutics. These results provide a framework to guide the therapy of a wide spectrum of human diseases.


Subject(s)
Adoptive Transfer/adverse effects , Gene Transfer Techniques , Receptors, Antigen, T-Cell/immunology , Recombinant Proteins/immunology , Retroviridae/genetics , T-Lymphocytes/immunology , T-Lymphocytes/transplantation , CD3 Complex/metabolism , CD4 Antigens/metabolism , Cohort Studies , Epigenesis, Genetic , Follow-Up Studies , Genetic Vectors/genetics , Genomics , Half-Life , Humans , Interleukin-2/administration & dosage , Interleukin-2/immunology , Mutagenesis, Insertional/genetics , Receptors, Antigen, T-Cell/genetics , Recombinant Proteins/genetics , T-Lymphocytes/metabolism , Time Factors , Transcription, Genetic , Transgenes/genetics
8.
PLoS Pathog ; 7(12): e1002439, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22174692

ABSTRACT

Lentiviruses such as HIV-1 traverse nuclear pore complexes (NPC) and infect terminally differentiated non-dividing cells, but how they do this is unclear. The cytoplasmic NPC protein Nup358/RanBP2 was identified as an HIV-1 co-factor in previous studies. Here we report that HIV-1 capsid (CA) binds directly to the cyclophilin domain of Nup358/RanBP2. Fusion of the Nup358/RanBP2 cyclophilin (Cyp) domain to the tripartite motif of TRIM5 created a novel inhibitor of HIV-1 replication, consistent with an interaction in vivo. In contrast to CypA binding to HIV-1 CA, Nup358 binding is insensitive to inhibition with cyclosporine, allowing contributions from CypA and Nup358 to be distinguished. Inhibition of CypA reduced dependence on Nup358 and the nuclear basket protein Nup153, suggesting that CypA regulates the choice of the nuclear import machinery that is engaged by the virus. HIV-1 cyclophilin-binding mutants CA G89V and P90A favored integration in genomic regions with a higher density of transcription units and associated features than wild type virus. Integration preference of wild type virus in the presence of cyclosporine was similarly altered to regions of higher transcription density. In contrast, HIV-1 CA alterations in another patch on the capsid surface that render the virus less sensitive to Nup358 or TRN-SR2 depletion (CA N74D, N57A) resulted in integration in genomic regions sparse in transcription units. Both groups of CA mutants are impaired in replication in HeLa cells and human monocyte derived macrophages. Our findings link HIV-1 engagement of cyclophilins with both integration targeting and replication efficiency and provide insight into the conservation of viral cyclophilin recruitment.


Subject(s)
Capsid Proteins/metabolism , Cell Nucleus/virology , Cyclophilin A/metabolism , HIV Infections/metabolism , HIV-1/physiology , Virus Replication , Active Transport, Cell Nucleus/physiology , Blotting, Western , Cell Line , Cell Nucleus/metabolism , HeLa Cells , Humans , Macrophages/metabolism , Macrophages/virology , Molecular Chaperones/metabolism , Nuclear Pore Complex Proteins/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Virus Replication/physiology
10.
Mol Ther ; 19(7): 1273-86, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21386821

ABSTRACT

A lentiviral vector encoding ß-globin flanked by insulator elements has been used to treat ß-thalassemia (ß-Thal) successfully in one human subject. However, a clonal expansion was observed after integration in the HMGA2 locus, raising the question of how commonly lentiviral integration would be associated with possible insertional activation. Here, we report correcting ß-Thal in a murine model using the same vector and a busulfan-conditioning regimen, allowing us to investigate efficacy and clonal evolution at 9.2 months after transplantation of bone marrow cells. The five gene-corrected recipient mice showed near normal levels of hemoglobin, reduced accumulation of reticulocytes, and normalization of spleen weights. Mapping of integration sites pretransplantation showed the expected favored integration in transcription units. The numbers of gene-corrected long-term repopulating cells deduced from the numbers of unique integrants indicated oligoclonal reconstitution. Clonal abundance was quantified using a Mu transposon-mediated method, indicating that clones with integration sites near growth-control genes were not enriched during growth. No integration sites involving HMGA2 were detected. Cells containing integration sites in genes became less common after prolonged growth, suggesting negative selection. Thus, ß-Thal gene correction in mice can be achieved without expansion of cells harboring vectors integrated near genes involved in growth control.


Subject(s)
Genetic Vectors/genetics , Lentivirus/genetics , beta-Thalassemia/therapy , Animals , Bone Marrow Transplantation , Chromatography, High Pressure Liquid , Flow Cytometry , HMGA2 Protein/genetics , Mice , beta-Globins/genetics , beta-Globins/metabolism , beta-Thalassemia/genetics , beta-Thalassemia/metabolism
11.
Nucleic Acids Res ; 39(11): e72, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21415009

ABSTRACT

Human genetic diseases have been successfully corrected by integration of functional copies of the defective genes into human cells, but in some cases integration of therapeutic vectors has activated proto-oncogenes and contributed to leukemia. For this reason, extensive efforts have focused on analyzing integration site populations from patient samples, but the most commonly used methods for recovering newly integrated DNA suffer from severe recovery biases. Here, we show that a new method based on phage Mu transposition in vitro allows convenient and consistent recovery of integration site sequences in a form that can be analyzed directly using DNA barcoding and pyrosequencing. The method also allows simple estimation of the relative abundance of gene-modified cells from human gene therapy subjects, which has previously been lacking but is crucial for detecting expansion of cell clones that may be a prelude to adverse events.


Subject(s)
Gene Targeting , Genetic Therapy , Sequence Analysis, DNA/methods , Bacteriophage mu/genetics , Cell Line , Humans , Polymerase Chain Reaction
12.
PLoS Pathog ; 7(3): e1001313, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21423673

ABSTRACT

Genome-wide siRNA screens have identified host cell factors important for efficient HIV infection, among which are nuclear pore proteins such as RanBP2/Nup358 and the karyopherin Transportin-3/TNPO3. Analysis of the roles of these proteins in the HIV replication cycle suggested that correct trafficking through the pore may facilitate the subsequent integration step. Here we present data for coupling between these steps by demonstrating that depletion of Transportin-3 or RanBP2 altered the terminal step in early HIV replication, the selection of chromosomal sites for integration. We found that depletion of Transportin-3 and RanBP2 altered integration targeting for HIV. These knockdowns reduced HIV integration frequency in gene-dense regions and near gene-associated features, a pattern that differed from that reported for depletion of the HIV integrase binding cofactor Psip1/Ledgf/p75. MLV integration was not affected by the Transportin-3 knockdown. Using siRNA knockdowns and integration targeting analysis, we also implicated several additional nuclear proteins in proper target site selection. To map viral determinants of integration targeting, we analyzed a chimeric HIV derivative containing MLV gag, and found that the gag replacement phenocopied the Transportin-3 and RanBP2 knockdowns. Thus, our data support a model in which Gag-dependent engagement of the proper transport and nuclear pore machinery mediate trafficking of HIV complexes to sites of integration.


Subject(s)
HIV/physiology , Host-Pathogen Interactions/physiology , Molecular Chaperones/metabolism , Nuclear Pore Complex Proteins/metabolism , beta Karyopherins/metabolism , Gene Expression Regulation, Viral , Gene Knockdown Techniques , HEK293 Cells , Humans , Molecular Chaperones/genetics , Nuclear Pore Complex Proteins/genetics , RNA, Small Interfering/genetics , Virus Replication , beta Karyopherins/genetics , gag Gene Products, Human Immunodeficiency Virus/genetics , gag Gene Products, Human Immunodeficiency Virus/metabolism
13.
Nature ; 467(7313): 318-22, 2010 Sep 16.
Article in English | MEDLINE | ID: mdl-20844535

ABSTRACT

The ß-haemoglobinopathies are the most prevalent inherited disorders worldwide. Gene therapy of ß-thalassaemia is particularly challenging given the requirement for massive haemoglobin production in a lineage-specific manner and the lack of selective advantage for corrected haematopoietic stem cells. Compound ß(E)/ß(0)-thalassaemia is the most common form of severe thalassaemia in southeast Asian countries and their diasporas. The ß(E)-globin allele bears a point mutation that causes alternative splicing. The abnormally spliced form is non-coding, whereas the correctly spliced messenger RNA expresses a mutated ß(E)-globin with partial instability. When this is compounded with a non-functional ß(0) allele, a profound decrease in ß-globin synthesis results, and approximately half of ß(E)/ß(0)-thalassaemia patients are transfusion-dependent. The only available curative therapy is allogeneic haematopoietic stem cell transplantation, although most patients do not have a human-leukocyte-antigen-matched, geno-identical donor, and those who do still risk rejection or graft-versus-host disease. Here we show that, 33 months after lentiviral ß-globin gene transfer, an adult patient with severe ß(E)/ß(0)-thalassaemia dependent on monthly transfusions since early childhood has become transfusion independent for the past 21 months. Blood haemoglobin is maintained between 9 and 10 g dl(-1), of which one-third contains vector-encoded ß-globin. Most of the therapeutic benefit results from a dominant, myeloid-biased cell clone, in which the integrated vector causes transcriptional activation of HMGA2 in erythroid cells with further increased expression of a truncated HMGA2 mRNA insensitive to degradation by let-7 microRNAs. The clonal dominance that accompanies therapeutic efficacy may be coincidental and stochastic or result from a hitherto benign cell expansion caused by dysregulation of the HMGA2 gene in stem/progenitor cells.


Subject(s)
Blood Transfusion , Genetic Therapy , HMGA2 Protein/metabolism , beta-Globins/genetics , beta-Globins/metabolism , beta-Thalassemia/genetics , beta-Thalassemia/therapy , Adolescent , Blood Cells/cytology , Blood Cells/metabolism , Bone Marrow Cells/cytology , Bone Marrow Cells/metabolism , Child, Preschool , Clone Cells/metabolism , Gene Expression , Genetic Vectors/genetics , HMGA2 Protein/genetics , Homeostasis , Humans , Lentivirus/genetics , Male , MicroRNAs/genetics , Organ Specificity , RNA, Messenger/analysis , RNA, Messenger/genetics , Time Factors , Transcriptional Activation , Young Adult , beta-Thalassemia/metabolism
14.
AIDS ; 23(12): 1461-71, 2009 Jul 31.
Article in English | MEDLINE | ID: mdl-19550285

ABSTRACT

OBJECTIVE: The goal of this study was to investigate whether the location of HIV integration differs in resting versus activated T cells, a feature that could contribute to the formation of latent viral reservoirs via effects on integration targeting. DESIGN: Primary resting or activated CD4 T cells were infected with purified X4-tropic HIV in the presence and absence of nucleoside triphosphates and genomic locations of integrated provirus determined. METHODS: We sequenced and analyzed a total of 2661 HIV integration sites using linker-mediated PCR and 454 sequencing. Integration site data sets were then compared to each other and to computationally generated random distributions. RESULTS: HIV integration was favored in active transcription units in both cell types, but integration sites from activated cells were found more often in genomic regions that were dense in genes, dense in CpG islands, and enriched in G/C bases. Integration sites from activated cells were also more strongly correlated with histone methylation patterns associated with active genes. CONCLUSION: These data indicate that integration site distributions show modest but significant differences between resting and activated CD4 T cells, and that integration in resting cells occurs more often in regions that may be suboptimal for proviral gene expression.


Subject(s)
CD4-Positive T-Lymphocytes/virology , HIV-1/physiology , Virus Integration/genetics , Base Sequence , Cells, Cultured , DNA, Viral/genetics , Genome , HIV-1/genetics , Humans , Lymphocyte Activation , Molecular Sequence Data , Virus Latency
15.
Genes Dev ; 23(5): 633-42, 2009 Mar 01.
Article in English | MEDLINE | ID: mdl-19270161

ABSTRACT

At least 8% of the human genome was formed by integration of retroviral DNA sequences. Here we analyze the forces directing the accumulation of human endogenous retroviruses (HERVs) by comparing de novo HERV integration targeting with the distribution of fixed HERV elements in the human genome. All known genomic HERVs are inactive due to mutation, but we were able to study integration targeting using a reconstituted consensus HERV-K (designated HERV-K(Con)). We found that HERV-K(Con) integrated preferentially in transcription units, in gene-rich regions, and near features associated with active transcription units and associated regulatory regions. In contrast, genomic HERV-K proviruses are found preferentially outside transcription units. The minority of genomic HERVKs present inside transcription units are in opposite transcriptional orientation relative to the host gene, the orientation predicted to be minimally disruptive to host mRNA synthesis, but de novo HERV-K(Con) integration within transcription units showed no orientation bias. We also found that the youngest HERV-K elements in the human genome showed a distribution intermediate between de novo HERV-K(Con) integration sites and older fixed HERV-Ks. These findings indicate that accumulation of HERVs in the human germline is a two-step process: integration targeting biases direct initial accumulation, then purifying selection leads to loss of proviruses disrupting gene function.


Subject(s)
Endogenous Retroviruses/metabolism , Genome, Human/genetics , Virus Integration/physiology , Cells/virology , Chromatin/metabolism , Chromosome Mapping , Endogenous Retroviruses/genetics , Histones/metabolism , Humans , Methylation , Virus Integration/genetics
16.
Methods ; 47(4): 261-8, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19038346

ABSTRACT

The question of where retroviral DNA becomes integrated in chromosomes is important for understanding (i) the mechanisms of viral growth, (ii) devising new anti-retroviral therapy, (iii) understanding how genomes evolve, and (iv) developing safer methods for gene therapy. With the completion of genome sequences for many organisms, it has become possible to study integration targeting by cloning and sequencing large numbers of host-virus DNA junctions, then mapping the host DNA segments back onto the genomic sequence. This allows statistical analysis of the distribution of integration sites relative to the myriad types of genomic features that are also being mapped onto the sequence scaffold. Here we present methods for recovering and analyzing integration site sequences.


Subject(s)
Gene Targeting/methods , Genome, Viral/genetics , Intracellular Space/virology , Virus Integration/genetics , Animals , Chromosomes/genetics , DNA, Viral/genetics , Humans
17.
Methods Mol Biol ; 435: 153-63, 2008.
Article in English | MEDLINE | ID: mdl-18370074

ABSTRACT

Many retrotransposons and retroviruses display integration site specificity. Increasingly, this specificity is found to result from recognition by the retroelement of specific chromatin states or DNA-bound protein complexes. A well-studied example of such a targeted retroelement is the Saccharomyces Ty5 retrotransposon, which integrates into heterochromatin at the telomeres and silent mating loci. Targeting is mediated by an interaction between Ty5 integrase (IN) and the heterochromatin protein silent information regulator 4 (Sir4). A small motif of IN, called the targeting domain, is responsible for this interaction. Ty5 integration can be directed to DNA sites outside of heterochromatin by tethering Sir4 to ectopic locations using fusion proteins between Sir4 and a DNA-binding domain. Alternatively, the targeting domain of Ty5 can be swapped with peptides that recognize other protein partners, thereby generating Ty5 elements with new target specificities. The mechanism of Ty5 target site choice suggests that integration specificity of other retrotransposons and retroviruses can be altered by engineering integrases to recognize DNA-bound protein partners. Retroelements can also be used to probe chromatin dynamics and the distribution of protein complexes on chromosomes. Here, we describe the basic assay by which Ty5 integration is monitored to sites of tethered Sir4.


Subject(s)
Retroelements/genetics , Saccharomyces/genetics , Binding Sites/genetics , DNA, Fungal/genetics , DNA, Fungal/metabolism , Electroporation , Escherichia coli/genetics , Integrases/genetics , Integrases/metabolism , Plasmids/genetics , Saccharomyces/metabolism , Silent Information Regulator Proteins, Saccharomyces cerevisiae/genetics , Silent Information Regulator Proteins, Saccharomyces cerevisiae/metabolism , Transformation, Genetic
18.
Mol Cell Biol ; 28(4): 1230-9, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18086891

ABSTRACT

Mobile elements rely on cellular processes to replicate, and therefore, mobile element proteins frequently interact with a variety of cellular factors. The integrase (IN) encoded by the retrotransposon Ty5 interacts with the heterochromatin protein Sir4, and this interaction determines Ty5's preference to integrate into heterochromatin. We explored the hypothesis that Ty5's targeting mechanism arose by mimicking an interaction between Sir4 and another cellular protein(s). Mutational analyses defined the requirements for the IN-Sir4 interaction, providing criteria to screen for cellular analogues. Esc1, a protein associated with the inner nuclear membrane, interacted with the same domain of Sir4 as IN, and 75% of mutations that disrupted IN-Sir4 interactions also abrogated Esc1-Sir4 interactions. A small motif critical for recognizing Sir4 was identified in Esc1. The functional equivalency of this motif and the Sir4-interacting domain of IN was demonstrated by swapping these motifs and showing that the chimeric IN and Esc1 proteins effectively target integration and partition DNA, respectively. We conclude that Ty5 targets integration by imitating the Esc1-Sir4 interaction and suggest molecular mimicry as a general mechanism that enables mobile elements to interface with cellular processes.


Subject(s)
Heterochromatin/metabolism , Molecular Mimicry , Retroelements/genetics , Saccharomyces cerevisiae Proteins/metabolism , Saccharomyces cerevisiae/metabolism , Amino Acid Motifs , Amino Acid Sequence , Conserved Sequence , DNA, Fungal/metabolism , Integrases/chemistry , Integrases/metabolism , Molecular Sequence Data , Mutation/genetics , Nuclear Proteins/chemistry , Nuclear Proteins/metabolism , Protein Binding , Protein Structure, Tertiary , Saccharomyces cerevisiae/cytology , Saccharomyces cerevisiae/enzymology , Saccharomyces cerevisiae Proteins/chemistry , Sequence Alignment , Silent Information Regulator Proteins, Saccharomyces cerevisiae/chemistry , Silent Information Regulator Proteins, Saccharomyces cerevisiae/metabolism
19.
Mol Cell ; 27(2): 289-299, 2007 Jul 20.
Article in English | MEDLINE | ID: mdl-17643377

ABSTRACT

The yeast Ty5 retrotransposon preferentially integrates into heterochromatin at the telomeres and silent mating loci. Target specificity is mediated by a small domain of Ty5 integrase (the targeting domain, TD), which interacts with the heterochromatin protein Sir4 and tethers the integration complex to target sites. Here we demonstrate that TD is phosphorylated and that phosphorylation is required for interaction with Sir4. The yeast cell, therefore, through posttranslational modification, controls Ty5's mutagenic potential: when TD is phosphorylated, insertions occur in gene-poor heterochromatin, thereby minimizing deleterious consequences of transposition; however, in the absence of phosphorylation, Ty5 integrates throughout the genome, frequently causing mutations. TD phosphorylation is reduced under stress conditions, specifically starvation for amino acids, nitrogen, or fermentable carbon. This suggests that Ty5 target specificity changes in response to nutrient availability and is consistent with McClintock's hypothesis that mobile elements restructure host genomes as an adaptive response to environmental challenge.


Subject(s)
Retroelements/genetics , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Amino Acid Substitution , Binding Sites/genetics , DNA, Fungal/genetics , DNA, Fungal/metabolism , Heterochromatin/genetics , Heterochromatin/metabolism , Integrases/chemistry , Integrases/genetics , Integrases/metabolism , Models, Biological , Phosphorylation , Serine/chemistry , Silent Information Regulator Proteins, Saccharomyces cerevisiae/genetics , Silent Information Regulator Proteins, Saccharomyces cerevisiae/metabolism , Two-Hybrid System Techniques
SELECTION OF CITATIONS
SEARCH DETAIL
...